NCT04501094 2022-03-22A Phase II Study of Bintrafusp Alfa (M7824) in Checkpoint Inhibitor Naive and Refractory Subjects With Urothelial CarcinomaNational Institutes of Health Clinical Center (CC)Phase 2 Terminated2 enrolled 13 charts